Home Precigen (PGEN): The Market Still Treats an Approved Drug as a Binary Bet – Rating Upgraded to Buy

Precigen (PGEN): The Market Still Treats an Approved Drug as a Binary Bet – Rating Upgraded to Buy

May 31, 2026 03:14 CST Updated 03:31
Precigen

Gene and Cell Therapy Developer